IndustryCompany release

IM Cannabis reports C$13.9M nine-month net loss as revenue slides to C$9.0M

IM Cannabis Corp. (IMCC) · Fri 13 Nov 2026

The cannabis company's unaudited results to 30 September 2026 show lower revenue, a smaller asset base and a continuing shareholders' deficit, despite fresh funding from convertible notes and a private placement.

IM Cannabis Corp. has published unaudited interim financial statements for the period ended 30 September 2026, which its board approved on 13 November 2026.

Revenue for the nine months fell to C$9.0m from C$15.8m a year earlier. The net loss widened to C$13.9m. The company says discontinued operations and deconsolidated subsidiaries contributed to the result.

Total assets dropped to C$13.7m, and the company reports a shareholders' deficit, meaning its liabilities exceed its assets. During the period it raised funds through convertible notes and a private placement.

The summary available does not give a segment breakdown, a geographic split or details of the financing terms, so the drivers behind the revenue decline and the scale of each funding source are not clear from the material reviewed.

What it means for your team

  • Partners, suppliers and distributors dealing with IM Cannabis may wish to take its financial position into account in counterparty risk reviews.
  • Teams handling quality agreements or supply continuity should check how restructuring, discontinued operations and deconsolidated subsidiaries affect responsibilities.
  • Market-access and commercial teams should read the full filing for segment and geographic detail, which is not covered in the summary.

Company's press release (SEC filing): IM Cannabis Corp. ↗

Article written by VigiEye from the official source (IM Cannabis Corp.). Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →